University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 23 of 25
Does Menopause Matter?
NCT00097994
Study of Oxaliplatin and Taxotere in Prostate Cancer
NCT00260611
Feasibility and Safety of Acupuncture for Systemic Lupus
NCT00493753
The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
NCT00222833
Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
NCT00400699
Tracking Optical Coherence Tomography
NCT00343603
The Effect of Mild Traumatic Brain Injury on Recovery From Injury
NCT00295074
Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
NCT00149643
Immunization Against Tumor Cells in Sezary Syndrome
NCT00099593
L-Carnosine for Bipolar I Disorder
NCT00177463
Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma
NCT00177242
Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma
NCT00630409
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
NCT00177684
Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
NCT00259649
Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095
NCT00177749
Muscle Lipid and Insulin Resistance in the Elderly
NCT00765505
Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
NCT00151125
Childhood Metabolic Markers of Adult Morbidity in Blacks
NCT01312051
Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes
NCT00177424
Mifepristone at Same Time Multicenter Study
NCT00269568
Cancer Detection in Pancreatic Cysts
NCT00222898
Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss
NCT00766298
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
NCT00280241
Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
NCT00128596
Reducing the Weight of Overweight Schizophrenia Patients
NCT00158366
Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study
NCT00222846
Developing an Instrument to Measure Personal Keyboarding Style
NCT00167336
Knee Stability Training for Knee Osteoarthritis (OA)
NCT00078624
Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
NCT00177294
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
NCT00158327
L-carnosine for Schizophrenia
NCT00177177
An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions
NCT00178126
Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
NCT00177827
Evaluating the Effectiveness of Brief Interpersonal Psychotherapy for Pregnant Women With Depression
NCT00292903
Further Enhancing Non-pharmacologic Therapy for Incontinence
NCT00177541
Role of Exercise for Wound Healing in the Larynx
NCT01009632
Managing Medications
NCT00222716
Study Looking at the Recovery of New Onset Cardiomyopathy
NCT00575211
Multi-Tracer PET Quantitation of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus
NCT00222781
The Surgical Gastrointestinal Diseases Registry Protocol
NCT00634153
Antidepressant Medication Plus Donepezil for Treating Late-life Depression
NCT00177671
Sertraline for the Prevention of Recurrent Postpartum Depression
NCT00276900
Cardiopulmonary Bypass and Inflammatory Response
NCT00167349
Resources to Enhance the Adjustment of Children (REACH)
NCT00820001
Mitochondrial Impairment in Muscle Insulin Resistance
NCT00222924
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
NCT00222794
Risperdal Consta for Bipolar Disorder
NCT00177164
Guidelines for Acute Sinusitis
NCT00132275
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
NCT00177554
A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection
NCT00177346
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.